Asia Insurance Post
  • Home
  • Articles
  • Blog
  • Data
  • Facts
  • Editorial
  • Interviews
Select Page

Maharashtra FDA cancels Johnson & Johnson baby powder manufacturing license

by AIP Online Bureau | Sep 17, 2022 | Health, Indian News, Policy, Regulation

The press note said that the samples of Johnson’s Baby Powder were declared “Not of Standard Quality”. FDA Maharashtra had taken the samples of Johnson’s Baby Powder at Pune and Nashik for quality check purposes Mumbai: Food & Drugs...
Next Entries »

Recent Posts

  • Public sector banks looks to scale up IT spend in view of cyber threat posed by Anthropic Mythos
  • Centre revamps Rashtriya Bal Swasthya Karyakram, adds mental health, NCD screening
  • New vehicle scrap norms may dent auto profits by Rs25K cr
  • Scindia launches nationwide mobile alert system for disaster emergencies
  • Finance Ministry notifies 100 pc FDI in insurance sector, amends FEMA Rules

Categories

  • Articles
  • Banking & Bancassurance
  • Blog
  • Breaking News!
  • Briefs
  • Climate, Environment, Renewable Energy
  • Data
  • Disaster & Management
  • Eco/Invest/Demography
  • Editorial
  • Events
  • Facts
  • Features
  • Health
  • Indian News
  • Intermediaries
  • International News
  • Interviews
  • Life
  • Main Menu
  • Non-Life
  • Pandemic
  • Pension & Social Security
  • Policy
  • Regulation
  • Reinsurance
  • Risk Management
  • Simple
  • Technology
  • Trends, Facts
  • Uncategorized
  • Wealth Management/ Philanthropy
  • Workplace/Employee Benefits
  • Home
  • Articles
  • Blog
  • Data
  • Facts
  • Editorial
  • Interviews
  • Eco/Invest/Demography
  • Indian News
  • International News
  • Health
  • Non-Life
  • Pandemic
  • Technology
  • Risk Management
  • Reinsurance
  • Banking & Bancassurance
  • Wealth Management/ Philanthropy